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Abstract
Purpose The study aimed to validate the Arabic version of the
Drug Use Disorders Identification Test (DUDIT) by (1)
assessing its factor structure, (2) determining structural valid-
ity, (3) evaluating item-total and inter-item correlation, and (4)
assessing its predictive validity.
Method The study population included 169 prison inmates,
51 patients with clinical diagnosis of substance used disorder,
and 53 students (N = 273). All participants completed the self-
report version of the Arabic DUDIT. After exploratory factor
analysis, internal consistency of the Arabic DUDITwas deter-
mined and external validation was performed.
Results Principal factor analysis showed that Arabic DUDIT
exhibited only one factor, which explained 66.9% of the var-
iance. Reliability based on Cronbach’s alpha was .95. When
compared to the DSM-IV substance use disorder diagnosis in
a clinical sample, DUDIT had an area under the curve (AUC)
of .98, with a sensitivity of .98 and a specificity of .90.
Conclusion The Arabic version of DUDIT is a valid and reli-
able tool for screening for drug use in Arabic-speaking
countries.
Keywords DUDIT . Drug use . Psychometric properties .
Arabic . Screening .MeSHe study
Introduction
Research in the field of psychiatry, including substance use
disorders, is quite rare in the Arabic world, and Morocco is no
exception to this matter [1]. As Gaferi et al. [2] pointed out,
there is an increased need for published research within the
field of substance use from Arabic-speaking countries, where
despite cultural, social, and/or religious facets, global reports
indicate an increasing prevalence of mental illness in this field
[3] possibly as a consequence of rapid development and mod-
ernization [2, 4, 5]. According to the latest report by the
International Narcotics Control Board (2014) [6], Morocco
(beside Afghanistan) is still the largest producer of cannabis
resin in the world, supplying the illicit markets of western and
central Europe and North Africa. This fact raises the obvious
point that Morocco might also be one of the leading countries
in terms of drug use or at least cannabis use. However, the
prevalence of substance abuse among citizens aged 15 years
and above, in the years 2004 and 2005, was 5.8% according
the nationwide survey on mental health and drug addiction
carried out by Morocco’s Ministry of Health [7]. This rate is
1.6 times lower than that measured in the USA [8]. A recent
study concluded that young adults’ involvement in substance
use in Morocco was substantially lower than the correspond-
ing rates in Europe or the USA [9]. Importantly, these studies
used the European ESPAD survey [10] and the Mini
International Neuropsychiatric Interview (MINI) [11], respec-
tively, to collect data about the prevalence of drug use/abuse.
In order to be able to compare data about the true prevalence
of drug use in Arabic-speaking countries to other international
information, we need validated and reliable instruments with
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good psychometric properties. Only then will we be able to
discern the underlying reasons of discrepancies in this global
matrix.
The early identification of individuals with drug problems
and evaluation of treatment strategies requires valid and reli-
able screening instruments. Several of these instruments have
focused on substance use and related constructs [12, 13].
Some of the most frequently used instruments for these pur-
poses are the Drug Abuse Screening Test (DAST) [14], the
CAGE-AID (Cut-down, Annoyed, Guilty, Eye-opener–
Adapted to Include Drugs) [15], the Alcohol, Smoking and
Substance Involvement Screening Test (ASSIST) [16], and
the Drug Use Disorders Identification Test (DUDIT) [17].
The DUDIT is one of the newest members in the above list
of screening instruments. It was developed with the specific
aims of assessing usage patterns and related problems, as well
as identifying the risk of harmful use or dependence according
to DSM-IVand ICD-10 by collecting information about drug
intake and associated problems. The DUDIT has been used in
European countries, such as Sweden, from where it originates
[18, 19]; Norway [20, 21]; Hungary [22]; and the Netherlands
[23, 24] but also used outside Europe, in the USA [25, 26],
South Africa [27], and Turkey [28, 29]. In the original publi-
cation on the DUDIT, Berman and colleagues [17] showed
that the instrument has good psychometric properties, such
as high internal consistency both in clinical (Cronbach’s alpha
.80) and in general populations (Cronbach’s alpha .93).
Several studies have confirmed the strong validity of the
DUDIT for assessing drug-related risk behavior and/or addic-
tion in various samples. These samples include the general
population [22, 26, 28], prisoners [17], probationers [23], of-
fenders with mental health problems [18], patients with sub-
stance use disorder (SUD) [30] or with a diagnosis of psycho-
sis [21], and in samples of adolescents and school-attending
youths [24, 27]. With this background, the present study aims
to validate and establish the psychometric properties of the
Arabic version of DUDIT with the help of a clinical sample
(where DSM-IV diagnoses are available), a prison sample
(where substance use often companies criminal behavior),
and a student sample (where the risk of substance use disorder
is minimal).
Subjects and Methods
During July 2013 and July 2014, we collected information
about somatic and mental health in defined samples of
Moroccans using the BMental and Somatic Health without
borders^ (MeSHe) survey. The MeSHe survey, constructed
by the project leader and co-author (NK), focuses on somatic
and mental health profiles coupled to substance use and ag-
gressive behavior in different countries. Alongside questions
about background information such as age and education and
a variety of health-related and demographic questions, the
Arabic version of the MeSHe survey includes the Arabic ver-
sion of DUDIT, produced in cooperation with the original
developers of this instrument at Karolinska Institute,
Stockholm, Sweden. In Morocco, participants were recruited
from three different settings with various pattern of drug use:
(a) substance-dependent out-patients from a medical and psy-
chological prevention center, (b) inmates with high possibility
of their criminal behavior coexisting drug use problem, and (c)
high school students with possible no drug use problem; each
samples helping in the assessment of the discriminative valid-
ity of the DUDIT. Participation of the MeSHe study is always
voluntary and involves the anonymous completion of the sur-
vey as self-reported questionnaire. In average (across all sub-




The sample of 61 substance dependent patients was recruited
from the medical and psychological prevention center in
Tangier, Morocco. Participation was 100% from this center
which is operating on an outpatient basis. Based on clinicians’
assessments, all participants met the DSM-IV criteria for sub-
stance use disorder (SUD). It should be noted that no differ-
ential diagnoses were provided for research due to patient–
doctor confidentiality. The number of female subjects
(n = 7) in this clinical sample was too low to be able to per-
form any reliable statistical analysis, which would have been
necessary based on the previously published gender sensitiv-
ity of DUDIT. Therefore, only male subjects (n = 54) were
included in the present study. This sample had a mean age of
38.37 (SD = 8.29, min = 19 max = 56), the mean education
dropout age was 15.55 (SD = 4.66), 72.2% achieved elemen-
tary or secondary school, 22.2% completed high school, 3.7%
achieved higher education, and 1.9% were unable to achieve
any qualification. A total of 59.3% of the patients were
unemployed.
Prison Sample
Data were collected from the male prison institution in
Meknes, Morocco. Random recruitment, assured by the pris-
on administration, was performed with exclusion of those who
lacked the academic skills required to understand and answer
the Arabic questionnaire. The initial sample size included 177
prisoners. Eight respondents (4.5%) were excluded due to
missing information about their age, resulting a final sample
of 169 inmates, which is approximately 7% of the prisoners
who were incarcerated during the specific period the data
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collections took place. This sample had a mean age of 30.88
(SD = 10.66, min = 15 max = 92). The mean education drop-
out age was 17.75 years (SD = 3.76); 44.4% successfully
achieved elementary or secondary school, 33.1% completed
high school, 20.1% achieved higher education, 1.2% did not
achieve any qualifications, and 1.2% were coded as missing.
Employment status showed that 18.9% of respondents were
unemployed.
Students
Students from the BSharif IDRISSI^ high school in Tetouan,
Morocco, were also asked to reply anonymously to our sur-
vey. Previously, the high school’s parents association ap-
proved the use of the survey based on anonymous and volun-
tary participation. At each grade (first, second, and third
grades), there were four classes in the school, of which two
were randomly selected to participate in the study. In each
class, the study was thoroughly explained, and the voluntary
and anonymous participation was emphasized. A member
from the researcher team and co-author (BZ) was present in
the classes while students completed the survey. No clinical
backgrounds were available for this sample. Ninety-six stu-
dents returned the questionnaire (representing 56.5% of the
entire student population of these six classes). In the present
analyses, only male subjects (n = 53) were included, with a
mean age of 17.26 (SD = .68).
Measures
The DUDIT is a screening instrument composed of 11 items
identifying consumption patterns and different problems relat-
ed to the use of drugs in general or clinical populations. The
scoring of DUDIT is based on two approaches: items 1 to 9 are
scored on a five-point Likert scale, while items 10 and 11 are
scored on three-point scale. The DUDIT score is calculated by
summing the scores on all items, engendering a maximum
score of 44 points. Cutoffs for screening of drug-related prob-
lems (≥6 for man) and of drug dependence (≥25 points) were
established in the original Swedish version of the question-
naire [17].
Official Translation of DUDIT
The translations were performed in two steps: the first
step was to translate DUDIT from English to Arabic,
and the second step was a back-translation by an inde-
pendent translator from Arabic to English. In 2014, after
several adjustments, the developer (Berman and col-
leagues) approved a final version of the Arabic




The present study is in agreement with the Helsinki declara-
tion. All participants received a written and oral presentation
of the study and its aims. They were assured that their answers
would not have any effect on their present sentence (in pris-
on), treatment plan (in clinical population), or academic per-
formance (students) and that no responses could be traced
back to the individual level. All answers were recorded on
an anonymous response sheet. Those who were not willing
to participate could simply leave or not enter the questionnaire
room, which provided a private, peaceful environment for
answering the BMental and Somatic Health without borders^
(MeSHe) survey.
Statistical Analysis
Sample characteristics were described via the use of descrip-
tive statistics, including means and standard deviation.
Principal factor analysis with oblique rotation was used to
assess the internal structure of the instrument; the factorability
of the data was assessed simultaneously by Bartlett’s test of
sphericity and the Kaiser–Meyer–Olkin (KMO) measure of
sampling adequacy. Internal reliability was tested using
Cronbach’s alpha coefficient; we also included inter-item, to-
tal item, and item-rest correlations (IRC). We have followed
George and Mallery (2003) rules of thumb for interpretation
of the alpha values:B ≥ .9 = Excellent, ≥.8 = Good, ≥.7 =
Acceptable, ≥.6 = Questionable, ≥.5 = Poor, and ≤.5 =
Unacceptable^ (p. 231) [31]. For the interpretation items’ fac-
tor loading, the following rules very applied: B ≥.7 =
Excellent, ≥.6 = Very good, ≥.5 = Good, ≥.4 = Fair, ≥.3 =
Poor^ (p. 649) [32]. External validation was performed by
the Mann–Whitney U test to analyze the difference between
the clinical sample and young adults. Effect size (r) was cal-
culated between young adult and clinical samples by dividing
the Z values by the square root of n (number of cases), while
Cohen’s criteria [33] for effect sizes were applied. Logistic
regression was undertaken using group membership (dichot-
omous variable: clinical sample and young adults) as the de-
pendent variable and the DUDIT score as the predictor vari-
able in a model. We then used the receiver operating charac-
teristic (ROC) analysis to evaluate sensitivity, specificity, and
cutoff scores. The AUC and the ROC curve were defined to
assess validity of the instrument by comparing the DUDIT
scores with DSM-IV diagnosis of substance use disorder. A
logistic regression model was used to determine the predictive
capacity of the DUDIT scores (independent variable) to
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identify dichotomous group membership category (dependent
variable where existing SUD diagnosis is coded as 1 and the
non-existing SUD diagnosis is coded as 0). All statistical anal-
yses were executed by SPSS for Windows version 21.0.
Results
Factorial Validity
The 11 DUDIT items were subject to principal factor analysis
and an assessment for suitability of data was performed. The
resulting Kaiser–Meyer–Olkin value was .93, while Bartlett’s
test of sphericity reached statistical significance, supporting
the factorability of data. Further, the scree plot revealed a
break just after the first factor with an eigenvalue >1 (7.36),
explaining 66.9% of the variance. The following eigenvalue
was .75 and accounted for just 6.81% of the total variance.
Factor loadings for all items ranged from .66 (item 10) to .87
(item 1) (see Table 1).
Internal Consistency
Cronbach’s alpha was calculated for DUDIT in the total study
population, showing excellent internal consistency (.95). The
Cronbach’s alpha coefficient was also calculated within each
group, proving a stable and strong correlation between the
items in each sample (.94 in the inmates’ sample, .89 in the
clinical sample and .94 in the young adults). The range of
item-total correlations was between .70 and .88.
Additionally, item-rest correlations were all above .65, which
shows that items highly correlate with the scale. Table 2 dis-
plays the inter-item, total item, and item-rest correlations.
Predictive Validity
ThemeanDUDITscore for the clinical sample diagnosedwith
SUD (N = 54) was 24.54 (SD = 12.05); this was significantly
(p < .001) higher than in the young adult sample with no
clinical SUD diagnosis (N = 53) (M = 1.34; SD = 4.43,
U = 64.000). The difference had a large effect size (Cohen’s
r = .85). A logistic regression model predicting group mem-
bership (SUD or no SUD) was statistically significant (χ2 (1,
N = 107) = 93.52), indicating that the reported DUDIT score
correlated highly with the existence of a SUD diagnosis. The
overall model explained between 58.3% (Cox and Snell R
square) and 77.7% (Nagelkerke R squared) of the variance
of group membership and showed that the DUDIT score was
effective in terms of correctly classifying the clinical sample
with SUD and individuals without existing SUD in 88.8% of
cases. Predictive validity was examined using ROC analysis,
where AUC reached .98 (p < .001, CI = .95–1.00) (Fig. 1).
Optimal sensitivity and specificity (.98 and .90, respectively)
matched a cutoff score of 3 (Table 3).
Discussion
This study has shown that the Arabic translation of DUDIT
has a high validity and reliability to identify individuals with
substance use/abuse in Arabic-language samples.
In matters of factorial validity, the one factor solution re-
vealed by principal axis factoring supports the statement that
the Arabic version of the DUDIT assesses a one-dimensional
construct. The factor loading ranged between Bvery good^
and Bexcellent.^ All items loaded highly in the main factor,
and those most strongly correlated with it concerned the fre-
quency of substance use (items 1 and 3), developing depen-
dence (item 5), uncontrolled use (item 6), and physical and
psychological discomfort (items 8 and 9). A similar one-factor
construct was previously identified in the Turkish, Dutch, and
American validation studies [23, 26, 29]. The original
Swedish study among a sample of drug users suggested a
three-factor solution, whereas only two factors were reported
in the general population [17]. Other validation studies also
showed a two-factor structure [22, 28]. The present study is
the fourth (after the Turkish, Dutch, and American studies) to
find a one-dimensional construct of the instrument. The main
similarities between these four studies were sample character-
istics such as male gender predominance and relatively het-
erogeneous samples including SUD patients and inmates.
Among these four studies, the country with highest GDP
(gross domestic product) per capita was the USA, followed
by the Netherlands, Turkey, and finally Morocco [34]; these
countries also have strong cultural differences and differing
attitudes to drug use and treatment of addiction.
Generally, the Arabic version of the DUDIT showed excel-
lent reliability and high external validity, and psychometric
properties were similar to those previously reported for other
language versions [17, 21–23, 27, 29, 30]. Internal consisten-
cy calculated for the total study population, as well as for the
separate samples, revealed excellent reliability (Cronbach’s
alpha close to or above .90), in accordance with previous
findings [22, 24, 26, 28–30]. Predictive validity based on
ROC analysis also showed excellent results. The AUC of
.98 reflects a high concurrent validity and indicates an ideal
fit between the DUDIT score and the DSM-IV diagnosis; this
indicates that the DUDIT can be considered Bexcellent^ at
separating drug users from non-drug-users. In order for a
screening instrument to be considered clinically useful, sensi-
tivity and specificity values must be above .80 [35]. The op-
timal sensitivity and specificity were coupled to a cutoff value
of 3 (sensitivity .98 and specificity .90). This is lower than the
value reported by Berman et al. [17] in a Swedish cohort
sample (cutoff for defining drug addiction ≥25, with a
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sensitivity of .90 and a specificity of .88), but comparable to
the value found in a Hungarian sample [22] (cutoff for defin-
ing drug addiction ≥2.1, with sensitivity of .95 and specificity
of .81). It is important to point out that the original article [17]
with the cutoff of 25 or more referred to DSM-IV/ICD-10
diagnoses based on a full diagnostic interview. The original
Swedish study was conducted in samples of hospitalized or
incarcerated subjects suffering from drug abuse or addiction,
while Matuszka et al. [22] and other authors (including the
present study) worked with a study population that included
less severe substance use problems and referred to problemat-
ic drug use including hazardous and harmful use. In our study,
each of the patients in the clinical sample had a SUD diagnosis
based on DSM-IV criteria, but we did not have enough infor-
mation to be able to differentiate subgroups according to the
severity of drug abuse. The cutoff would obviously be much
Table 2 Inter-item, total-item, and item-rest correlations (IRC) for DUDIT (N = 240)
DUDIT items 1 2 3 4 5 6 7 8 9 10 11 IRC
1 How often do you use drugs other than alcohol? 1 .84
2 Do you use more than one type of drug on the same occasion? .65 1 .66
3 How many times do you take drugs on a typical day when you use
drugs?
.80 .69 1 .80
4 How often are you influenced heavily by drugs? .74 .57 .66 1 .77
5 Over the past year, have you felt that your longing for drugs was so
strong that you could not resist it?
.68 .47 .63 .64 1 .81
6 Has it happened, over the past year, that you have not been able to stop
taking drugs once you started?
.62 .52 .65 .66 .75 1 .79
7 How often over the past year have you taken drugs and then neglected
to do something you should have done?
.61 .54 .63 .56 .72 .72 1 .75
8 How often over the past year have you needed to take a drug the
morning after heavy drug use the day before?
.68 .58 .71 .63 .73 .81 .71 1 .83
9 How often over the past year have you had guilt feelings or a bad
conscience because you used drugs?
.78 .54 .66 .69 .69 .67 .65 .70 1 .84
10 Have you or anyone else been hurt (mentally or physically) because you
used drugs?
.59 .43 .44 .58 .57 .50 .44 .53 .64 1 .65
11 Has a relative or a friend, a doctor or a nurse, or anyone else, been
worried about your drug use or said to you that you should stop using
drugs?
.69 .46 .63 .58 .70 .60 .60 .67 .77 .59 1 .77
DUDIT score .88 .72 .84 .82 .84 .83 .79 .86 .88 .70 .82
All correlations are significant at p < .001
DUDIT Drug Use Disorders Identification Test
Table 1 Factor loadings for
DUDIT items (N = 240) DUDIT Factor
1
1 How often do you use drugs other than alcohol? .86
2 Do you use more than one type of drug on the same occasion? .68
3 How many times do you take drugs on a typical day when you use drugs? .82
4 How often are you influenced heavily by drugs? .79
5 Over the past year, have you felt that your longing for drugs was so strong that you could not
resist it?
.83
6 Has it happened, over the past year, that you have not been able to stop taking drugs once you
started?
.82
7 How often over the past year have you taken drugs and then neglected to do something you
should have done?
.78
8 How often over the past year have you needed to take a drug the morning after heavy drug use
the day before?
.85
9 How often over the past year have you had guilt feelings or a bad conscience because you used
drugs?
.86
10 Have you or anyone else been hurt (mentally or physically) because you used drugs? .66
11 Has a relative or a friend, a doctor or a nurse, or anyone else, been worried about your drug use
or said to you that you should stop using drugs?
.79
DUDIT Drug Use Disorders Identification Test
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lower for hazardous and harmful use than for dependence or
abuse. This important difference in the study populations is
reflected in the mean scores in DUDIT. While students had
very similar mean scores in both the Hungarian and the pres-
ent Moroccan sample (1.39 and 1.34, respectively), we found
clear differences in our clinical samples. The mean score of
the clinical sample onDUDITwas the lowest in the Hungarian
sample (M = 14.07 for mandatory drug treatment program
participants and M = 17.71 for outpatient treatment program
participants) [22], followed by that in the Moroccan SUD
sample (M = 24.5) and the original Swedish report (32.7
points) [17]. One explanation of this is that the low cutoff
score could be due to the differences in sample characteristics.
The low cutoff could also reveal eventual cultural differences
in attitudes to drug abuse and addicts, and emphasize the need
for nationally validated drug inventories.
In our clinical sample, seven patients had between two and
six points on the DUDIT, which should be impossible consid-
ering that each of these patients had a SUD diagnosis accord-
ing DSM-IVand that they were hospitalized for their drug use
problem. However, because the study was a validation of a
self-report instrument, we did not exclude those persons from
the analyses. Self-report as a method includes the possibility
of misunderstanding the questions and the possibility of
Bunder-scoring^ based on shame or fear of admitting the truth
about something (drug use, in our case). This is supported by
the fact that when we use the suggested cutoff (≥3 points) to
select those with drug use problems in our student sample (in
average 17 years old), six students (11%) were identified. This
rate is comparable to Swedish ninth-class boys (on average
15 years old), where 7% of whom reported use of narcotics
[36].
Fig. 1 Receiver operating
characteristic (ROC) curve for
DUDIT score (independent
variable) and group membership
(dependent variable). Area under
the curve (AUC) was .98
(p < .001, CI = .95–1)
Table 3 Specificity,
sensitivity, and cutoff
scores for the DUDIT
(N = 107)











aOptimal sensitivity and specificity in the
Arabic DUDIT for identification of drug
dependence
b Suggested cutoff for drug-related prob-
lems [17]
c Suggested cutoff for drug dependence
[17]
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Limitations
This study has certain limitations. One is the exclusion of
females in the study due to male gender predominance, which
could have an effect on the results. Even though it can be
useful and acceptable to only report results for males, further
assessment focusing on female gender is required in order to
acquire better insight regarding patterns of use among women.
Furthermore, the absence of clinical diagnoses in both offend-
er and student samples raises concerns about sensitivity and
specificity of the instrument; future studies on predictive va-
lidity in a clinically diagnosed sample are highly
recommended.
Conclusion
The Arabic version of DUDIT has excellent reliability and
high validity. These psychometric properties justify the use
of this instrument for drug use assessment and for testing the
treatment process in different settings, making it simple for
clinicians and researchers to collect data from targeted groups.
Moreover, our findings emphasize the need to investigate the
cultural aspects of mental ill health and the use of locally
adapted and validated measures in research.
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